Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2640 of 5804
-
New hope for advanced cancers? first human trial of XL309 begins
Disease control Recruiting nowThis is a first-in-human (FIH), multicenter, open-label Phase I study to investigate the safety, tolerability, preliminary antitumor activity, as well as pharmacokinetics (PK) and pharmacodynamics of XL309 (previously ISM3091) administered alone or in combination with olaparib in…
Phase: PHASE1 • Sponsor: Exelixis • Aim: Disease control
Last updated Jun 26, 2026 14:03 UTC
-
Brain surgery bleeding breakthrough? drug may cut blood loss
Symptom relief Recruiting nowThe goal of this clinical trial is to test the effect of a drug called tranexamic acid (TXA) on reducing blood loss in participants undergoing surgery to remove brain tumors. The main questions it aims to answer are: 1. Does TXA 20 mg/kg IV bolus of TXA, and 1 mg/kg/hr infusion …
Phase: PHASE3 • Sponsor: Stephen Lownie • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
Brain zapping study seeks to rewire social circuits in autism
Knowledge-focused Recruiting nowThe goal of this observational study is to test the modulation effect of different transcranial magnetic stimulation (TMS) on the neural network supporting our ability to create mental representations of others (also known as mentalizing) in young adults with autism. The main que…
Phase: NA • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Smartwatch workout plan aims to boost activity in kids with rare lung condition
Symptom relief Recruiting nowChildren with pulmonary hypertension (PH) engage in less physical activity than their peers. This is a concern since adult data support exercise as a non-pharmacologic treatment for PH. Despite adult data, therapeutic exercise has not been widely adopted in pediatric PH. Investig…
Phase: NA • Sponsor: Children's Hospital of Philadelphia • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Tailored therapy for kids with OCD: a new hope?
Symptom relief OngoingThe primary purpose of this study is to learn whether personalized assessment of obsessive-compulsive disorder (OCD) symptoms in childhood OCD using mobile health technology are feasible and acceptable for youth and parents. The investigators will also examine whether personalize…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
Could a common antipsychotic curb opioid cravings in cancer patients?
Symptom relief Recruiting nowTo learn about the effectiveness of taking the antipsychotic medication olanzapine to help lower opioid craving.
Phase: PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Can a talking therapy ease anxiety in autistic toddlers?
Symptom relief CompletedA within-subjects design will be used for this preliminary investigation of four biomarkers across two contexts of use: prediction of treatment response (i.e., stratification) and quantification of response (i.e., change).
Phase: NA • Sponsor: Boston Children's Hospital • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC
-
New program aims to clear the air in homes with kids
Prevention Recruiting nowWhile smoking and exposure to second-hand tobacco smoke (SHS) in most public places is addressed by smoke-free regulations, the exposure to SHS at private places, such as homes, is still prevalent in Spain and represents a significant public health challenge. Main objective of t…
Phase: NA • Sponsor: Institut Català d'Oncologia • Aim: Prevention
Last updated Jun 27, 2026 14:01 UTC
-
Navigator program boosts HIV prevention in malawian men
Prevention CompletedTo evaluate the potential benefit(s), acceptability, and associated costs of a systems navigator-delivered HIV prevention intervention in promoting and supporting persistent use of evidence-based HIV pre-exposure prophylaxis (PrEP) among heterosexual men receiving care for sexual…
Phase: NA • Sponsor: HIV Prevention Trials Network • Aim: Prevention
Last updated Jun 27, 2026 08:03 UTC
-
Scientists investigate why breast cancer beats treatments
Knowledge-focused Recruiting nowThis study will evaluate mechanisms of resistance to anti-breast cancer therapies in tumor and blood samples from participants with human epidermal growth factor receptor (HER2) positive, hormone receptor (HR) positive or triple negative breast cancer.
Phase: PHASE4 • Sponsor: Hoffmann-La Roche • Aim: Knowledge-focused
Last updated Jul 08, 2026 00:00 UTC
-
New study tracks immune effects of NMOSD drug over years
Disease control OngoingThe purpose of this study is to understand the effects of long-term treatment with inebilizumab on circulating levels of immunoglobulins, B-cell counts, and other safety measures, and to further monitor repletion of immunoglobins and B-cell counts in participants with NMOSD who d…
Phase: PHASE4 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Dietary additives may worsen colitis – study tests clean eating
Disease control Recruiting nowThis is a prospective clinical intervention trial where patients with moderately active ulcerative colitis are randomized to either normal healthy diet or a diet with elimination of emulsifying agents within the E 400-group with special respect to carragenan, CMC and polysorbates…
Phase: NA • Sponsor: Region Skane • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Can a new drug combo tame the weight gain from a key schizophrenia medication?
Disease control Recruiting nowThe main question this study is trying to answer is whether lumateperone, an FDA-approved antipsychotic drug, can help reduce possible side effects of clozapine, such as weight gain and elevated levels of sugar and bad cholesterol. Participants will be randomly assigned to eithe…
Phase: PHASE4 • Sponsor: University of Massachusetts, Worcester • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Can an app lower your blood pressure? new study says maybe.
Disease control OngoingThis clinical trial with 328 patients with primary hypertension aims to investigate the effectiveness of the self-guided digital application liebria for patients with primary hypertension.
Phase: NA • Sponsor: Gaia AG • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New study tests if a lower dose of a stronger blood thinner can prevent heart attacks during stent procedures
Disease control Recruiting nowThe proposed study aims to assess the antiplatelet effects of more potent oral P2Y12 inhibition with low-dose ticagrelor (60 mg bid) compared with standard of care clopidogrel in patients with a high ABCD-GENE score (≥10). We hypothesize that ticagrelor is associated with better …
Phase: PHASE4 • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Jumping back to strength: plyometrics tested for burn recovery in kids
Symptom relief CompletedPediatric burn survivors may experience persistent deficits in lower-limb strength, explosive power, and functional performance after hospital discharge. This randomized controlled trial evaluated whether a 12-week supervised plyometric training program improves lower-extremity m…
Phase: NA • Sponsor: Qassim University • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
Can your Child's DNA predict the best ADHD drug?
Knowledge-focused Recruiting nowThe "Pharmacogenomics of Stimulant Treatment Response" (PGx-STaR) study aims to identify genetic profiles related to methylphenidate treatment outcomes in children and adolescents aged 6-24 with Attention deficit/hyperactivity disorder (ADHD).
Sponsor: University of Calgary • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC
-
Autism smell and taste study tests natural supplement
Symptom relief CompletedAutism Spectrum Disorder (ASD) is frequently associated with atypical sensory processing across visual, auditory, olfactory, and gustatory domains, variably affecting quality of life and requiring personalized treatment. Palmitoylethanolamide (PEA), an endogenous fatty acid amide…
Phase: NA • Sponsor: University of Campania Luigi Vanvitelli • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
Can brain zaps boost social skills in kids with autism?
Symptom relief ENROLLING_BY_INVITATIONResults of the application of 100 sessions of tDCS for 12 months in children between 6 and 11 years old with autism spectrum disorder with rare diseases, genetic problems or PANDAS
Phase: PHASE1 • Sponsor: Spanish Foundation for Neurometrics Development • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Back exercises may soothe menstrual cramps, study finds
Symptom relief CompletedThe study, designed as a randomized controlled experimental trial, was conducted at Tonya Vocational School. Institutional approval was obtained to carry out the study at Tonya Vocational School (Appendix-). Participants who met the inclusion and exclusion criteria and voluntaril…
Phase: NA • Sponsor: Sevtap Günay • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC